The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications Elisa MenozziAnthony H. V. Schapira Leading Article Open access 03 April 2024 Pages: 315 - 331
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis Fernando L. PaganPaul E. SchulzGregory M. Pontone Therapy in Practice Open access 08 April 2024 Pages: 333 - 347
CNS Viral Infections—What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches Ming SunMartijn L. MansonElizabeth C. M. de Lange Review Article Open access 05 April 2024 Pages: 349 - 373
Oral Delta-9-Tetrahydrocannabinol (THC) Increases Parasympathetic Activity and Supraspinal Conditioned Pain Modulation in Chronic Neuropathic Pain Male Patients: A Crossover, Double-Blind, Placebo-Controlled Trial Libat WeizmanHaggai SharonGiris Jacob Original Research Article Open access 10 April 2024 Pages: 375 - 385
Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial Mohamed G. ZeinhomAhmed ElbassiounySherihan Rezk Ahmed Original Research Article Open access 15 April 2024 Pages: 387 - 398
The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations Rachel GoldsteinNatalie RabkinMordechai Muszkat Original Research Article Open access 23 March 2024 Pages: 399 - 408